-
. Contribute to undergraduate, graduate (PhD, M.S.) and professional (PharmD) education. Actively participate in divisional/departmental program metrics for academic achievement. Lead or contribute to "team
-
evaluation of cardiovascular toxicity associated with environmental exposure or cancer drug. We are currently seeking a candidate to lead a new research program on how tyrosine kinase inhibitors (TKIs) induce
-
Program, the Bio5 Institute, Arizona Cancer Center, Arizona Center for Drug Discovery and Development and Southwester Environmental Health Sciences Center. Outstanding UA benefits include health, dental
-
in the lab of Dr. Jianqin Lu at the University of Arizona. The candidate should be equipped with strong medicinal and bioconjugation chemistry skill, and the ability to design and synthesize novel drug
-
tissue, and cell-based models, as well as metabolism, mitochondrial dynamics, phosphoproteomics, single-cell multiomics, biomarker diagnostics, and drug discovery and testing. Successful candidates will